Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 11, 2016 16:30 ET | Source: Innocoll Holdings plc

Innocoll to Report Fourth Quarter 2015 Financial Results and Host Webcast and Conference Call on March 17, 2016

ATHLONE, Ireland, March 11, 2016 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) (the "Company"), a global, commercial stage, specialty pharmaceutical company with late stage development programs...
December 17, 2015 08:30 ET | Source: Innocoll Holdings plc

Innocoll AG Appoints Charles Katzer as Head of Manufacturing and Technical Operations

ATHLONE, Ireland, Dec. 17, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (NASDAQ:INNL) announced that Charles Katzer has been appointed head of Manufacturing and Technical Operations effective immediately....
December 09, 2015 16:30 ET | Source: Innocoll Holdings plc

Innocoll AG Announces Plan to Move Corporate Domicile to Ireland

ATHLONE, Ireland, Dec. 09, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (NASDAQ:INNL) today announced that its supervisory board has unanimously approved a plan to move the company’s legal domicile from...
November 11, 2015 08:00 ET | Source: Innocoll Holdings plc

Innocoll AG Announces Third Quarter 2015 Financial and Operating Results and Corporate Update

ATHLONE, Ireland, Nov. 11, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL), a global, commercial-stage, specialty pharmaceutical company that develops, manufactures and supplies a range of...
November 04, 2015 16:05 ET | Source: Innocoll Holdings plc

Innocoll to Report Third Quarter 2015 Financial Results and Host Webcast and Conference Call on November 11, 2015

ATHLONE, Ireland, Nov. 04, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of...
September 16, 2015 08:00 ET | Source: Innocoll Holdings plc

Innocoll AG Announces First Patient Dosed in the XaraColl MATRIX-2 Phase 3 Study for the Treatment of Postoperative Pain

ATHLONE, Ireland, Sept. 16, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (NASDAQ:INNL), a global, commercial-stage, specialty pharmaceutical company that develops, manufactures and supplies a range of...
September 14, 2015 08:00 ET | Source: Innocoll Holdings plc

Innocoll AG Announces Departure of Chief Medical Officer

ATHLONE, Ireland, Sept. 14, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (NASDAQ:INNL) announced that James P. Tursi, M.D., will depart Innocoll to pursue another opportunity. Dr. Tursi will remain with...
September 02, 2015 08:00 ET | Source: Innocoll Holdings plc

Innocoll AG Announces First Patient Dosed in the XaraColl MATRIX-1 Phase 3 Study for the Treatment of Postoperative Pain

ATHLONE, Ireland, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (NASDAQ:INNL), a global, commercial-stage, specialty pharmaceutical company that develops, manufactures and supplies a range of...
August 14, 2015 08:00 ET | Source: Innocoll Holdings plc

Innocoll AG Announces Second Quarter 2015 Financial and Operating Results and Updates Late-Stage Product Portfolio Progress

ATHLONE, Ireland, Aug. 14, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL), a global, commercial-stage, specialty pharmaceutical company that develops, manufactures and supplies a range of...
August 13, 2015 08:00 ET | Source: Innocoll Holdings plc

Innocoll AG Appoints Rich Fante as Chief Commercial Officer and Head of Business Development

ATHLONE, Ireland, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (NASDAQ:INNL) announced that Rich Fante has been appointed Chief Commercial Officer and Head of Business Development effective August...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right